Endovision Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 54

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.03M

  • Investors
  • 7

Endovision General Information

Description

Developer of medical devices intended to improve human health and medical treatments. The company studies, develops, and manufactures a wide range of products, mainly biomaterials, spinal endoscopes, arthroscopes, endoscopes, laparoscopes, and gynecologic endoscopes, with continuous research and development activities for the next-generation and advanced bio- and mechanical medical device market, enabling the healthcare industry with safe and satisfactory products and services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 66-26 Dongnae
  • Dong-gu
  • Daegu
  • South Korea
+82
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Vertical(s)
Corporate Office
  • 66-26 Dongnae
  • Dong-gu
  • Daegu
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endovision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 26-Mar-2026 $2.03M Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view Endovision’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Endovision Patents

Endovision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026121812-A1 Method for preparing joint cavity repair composition, and joint cavity repair composition Pending 03-Dec-2024
EP-4736899-A1 Incise drape and manufacturing method thereof Pending 04-Nov-2024
US-20260124014-A1 Incise drape and manufacturing method thereof Pending 04-Nov-2024
WO-2023249142-A1 One-touch three-way medical stopcock Inactive 23-Jun-2022
WO-2023243741-A1 Spinal surgery device Inactive 14-Jun-2022
To view Endovision’s complete patent history, request access »

Endovision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endovision Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
A-Stone Ventures Venture Capital Minority
Comes Investment Venture Capital Minority
NH Venture Investment Venture Capital Minority
Trust Venture Investment Venture Capital Minority
Wooshin Venture Investment Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Endovision FAQs

  • When was Endovision founded?

    Endovision was founded in 2013.

  • Where is Endovision headquartered?

    Endovision is headquartered in Daegu, South Korea.

  • What is the size of Endovision?

    Endovision has 54 total employees.

  • What industry is Endovision in?

    Endovision’s primary industry is Medical Supplies.

  • Is Endovision a private or public company?

    Endovision is a Private company.

  • What is Endovision’s current revenue?

    The current revenue for Endovision is .

  • How much funding has Endovision raised over time?

    Endovision has raised $2.03M.

  • Who are Endovision’s investors?

    A-Stone Ventures, Comes Investment, NH Venture Investment, Trust Venture Investment, and Wooshin Venture Investment are 5 of 7 investors who have invested in Endovision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process